175 related articles for article (PubMed ID: 38075039)
21. FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.
Azagra R; Roca G; Encabo G; Aguyé A; Zwart M; Güell S; Puchol N; Gene E; Casado E; Sancho P; Solà S; Torán P; Iglesias M; Gisbert MC; López-Expósito F; Pujol-Salud J; Fernandez-Hermida Y; Puente A; Rosàs M; Bou V; Antón JJ; Lansdberg G; Martín-Sánchez JC; Díez-Pérez A; Prieto-Alhambra D
BMC Musculoskelet Disord; 2012 Oct; 13():204. PubMed ID: 23088223
[TBL] [Abstract][Full Text] [Related]
22. Performance of FRAX in Men With Prostate Cancer: A Registry-Based Cohort Study.
Ye C; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA; Leslie WD
J Bone Miner Res; 2023 May; 38(5):659-664. PubMed ID: 36807916
[TBL] [Abstract][Full Text] [Related]
23. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.
Leslie WD; Majumdar SR; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
Osteoporos Int; 2012 Jan; 23(1):391-7. PubMed ID: 21365460
[TBL] [Abstract][Full Text] [Related]
24. Performance of fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on suppressive antiretroviral therapy.
Tsai MS; Zhang JY; Sun HY; Liu WC; Wu PY; Yang CJ; Hung CC
J Int AIDS Soc; 2019 Aug; 22(8):e25383. PubMed ID: 31423752
[TBL] [Abstract][Full Text] [Related]
25. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
26. Clinical risk factor status in patients with vertebral fracture but normal bone mineral density.
Kadri A; Binkley N; Daffner SD; Anderson PA
Spine J; 2022 Oct; 22(10):1634-1641. PubMed ID: 35680015
[TBL] [Abstract][Full Text] [Related]
27. Preoperative bone health assessment and optimization in spine surgery.
Anderson PA; Kadri A; Hare KJ; Binkley N
Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
[TBL] [Abstract][Full Text] [Related]
28. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.
James H; Aleksic I; Bienz MN; Pieczonka C; Iannotta P; Albala D; Mariados N; Mouraviev V; Saad F
Urology; 2014 Jul; 84(1):164-8. PubMed ID: 24976229
[TBL] [Abstract][Full Text] [Related]
29. FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture.
Sagalla N; Colón-Emeric C; Sloane R; Lyles K; Vognsen J; Lee R
Osteoporos Int; 2021 Mar; 32(3):467-472. PubMed ID: 32885318
[TBL] [Abstract][Full Text] [Related]
30. Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
Hung WC; Lin YL; Cheng TT; Chin WL; Tu LT; Chen CK; Yang CH; Wu CH
Osteoporos Int; 2024 Jan; 35(1):129-141. PubMed ID: 37728768
[TBL] [Abstract][Full Text] [Related]
31. Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
Ku EJ; Yoo WS; Lee EK; Ahn HY; Woo SH; Hong JH; Chung HK; Park JW
J Clin Endocrinol Metab; 2021 Nov; 106(12):3655-3667. PubMed ID: 34302730
[TBL] [Abstract][Full Text] [Related]
32. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
[TBL] [Abstract][Full Text] [Related]
33. Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
Vendrami C; Marques-Vidal P; Gonzalez Rodriguez E; Hans D; Waeber G; Lamy O
Osteoporos Int; 2022 Jan; 33(1):195-204. PubMed ID: 34409507
[TBL] [Abstract][Full Text] [Related]
34. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
35. FRAX score with and without bone mineral density: a comparison and factors affecting the discordance in osteoporosis treatment in Thais.
Teeratakulpisarn N; Charoensri S; Theerakulpisut D; Pongchaiyakul C
Arch Osteoporos; 2021 Feb; 16(1):44. PubMed ID: 33635451
[TBL] [Abstract][Full Text] [Related]
36. Administrative healthcare data applied to fracture risk assessment.
Yang S; Leslie WD; Morin SN; Lix LM
Osteoporos Int; 2019 Mar; 30(3):565-571. PubMed ID: 30554259
[TBL] [Abstract][Full Text] [Related]
37. Beijing Friendship Hospital Osteoporosis Self-Assessment Tool for Elderly Male (BFH-OSTM) vs Fracture Risk Assessment Tool (FRAX) for identifying painful new osteoporotic vertebral fractures in older Chinese men: a cross-sectional study.
An N; Lin JS; Fei Q
BMC Musculoskelet Disord; 2021 Jun; 22(1):596. PubMed ID: 34182964
[TBL] [Abstract][Full Text] [Related]
38. Fracture risk assessment in celiac disease: a registry-based cohort study.
Duerksen DR; Lix LM; Johansson H; McCloskey EV; Harvey NC; Kanis JA; Leslie WD
Osteoporos Int; 2021 Jan; 32(1):93-99. PubMed ID: 32748311
[TBL] [Abstract][Full Text] [Related]
39. Is there an interaction between socioeconomic status and FRAX 10-year fracture probability determined with and without bone density measures? Data from the Geelong Osteoporosis Study of female cohort.
Brennan SL; Quirk SE; Hosking SM; Kotowicz MA; Holloway KL; Moloney DJ; Dobbins AG; Pasco JA
Calcif Tissue Int; 2015 Feb; 96(2):138-44. PubMed ID: 25578145
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the validity of osteoporosis and fracture risk assessment tools (IOF One Minute Test, SCORE, and FRAX) in postmenopausal Palestinian women.
Kharroubi A; Saba E; Ghannam I; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):6. PubMed ID: 28013446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
